- FDA Law Blog has a great post about a very interesting district court decision concerning Apotex’s attempt to market generic Prilosec before AstraZeneca’s pediatric exclusivity expires.
- Congress passed FDA reform legislation this week, albeit without provisions for biosimilars. (AP article; FDA Law Blog; PhRMA release).
- In the Pipeline is a great blog by a medicinal chemist. This week, it has a post about the importance of patents to drug development.
- Globes reported that according to Merrill Lynch analyst Gregg Gilbert, Wyeth and Teva may settle the Protonix litigation.
- Pharmalot posted this week on the rising cost of biotech drugs to big pharma.
- Spicy IP has an interesting post this week on Indian pharmaceutical lifecycle management.
Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Orange Book Blog 
Leave a comment